These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14574929)

  • 1. [Radiotherapy for locally relapsed rectal cancer].
    Fukuda H
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():431-4. PubMed ID: 14574929
    [No Abstract]   [Full Text] [Related]  

  • 2. Irinotecan in preoperative combined-modality therapy for locally advanced rectal cancer.
    Mitchell EP
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):56-9. PubMed ID: 11200151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality therapy for rectal cancer using irinotecan.
    Minsky BD
    Oncology (Williston Park); 2002 May; 16(5 Suppl 5):35-8. PubMed ID: 12109805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality treatment for rectal cancer.
    Zhu AX; Willett CG
    Semin Oncol; 2005 Feb; 32(1):103-12. PubMed ID: 15726512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: NCCN colon and rectal cancer clinical practice guidelines.
    Kiel K; Engstrom PF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-14-8. PubMed ID: 23570093
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results.
    Pucciarelli S; Urso E; DeSalvo GL; Aschele C; Friso ML; Rugge M; Toppan P; Bruttocao A; Fabris G; Ferraro B; Lonardi S; Frego M; Finco C; Lise M; Nitti D
    Arch Med Res; 2006 Oct; 37(7):860-5. PubMed ID: 16971226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined-modality therapy of rectal cancer with irinotecan-based regimens.
    Minsky BD
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):49-55. PubMed ID: 15685836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer.
    Choi HJ; Kim NK; Keum KC; Cheon SH; Shin SJ; Baik SH; Choen JH; Rha SY; Roh JK; Jeung HC; Chung HC; Ahn JB
    Radiother Oncol; 2008 Jun; 87(3):361-6. PubMed ID: 18439695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of rectal carcinoma].
    Schultze J; Kimmig B
    Rontgenpraxis; 2001; 53(5):221-5. PubMed ID: 11341018
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined-modality therapy for rectal cancer: future prospects.
    Czito BG; Willett CG; Bendell JC
    Clin Colorectal Cancer; 2007 Sep; 6(9):625-33. PubMed ID: 17945034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
    Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
    Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical therapy of early rectal carcinoma.
    Curley SA; Roh MS; Rich TA
    Hematol Oncol Clin North Am; 1989 Mar; 3(1):87-102. PubMed ID: 2645273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in rectal cancer.
    Fuchs CS
    Lancet; 1996 Dec; 348(9042):1600. PubMed ID: 8961983
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
    Kalofonos HP; Kardamakis D; Bamias A; Skarlos D; Papakostas P; Bafaloukos D; Sakantamis A; Pavlidis N; Fountzilas G
    Anticancer Res; 2003; 23(2C):1687-91. PubMed ID: 12820441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effecting observation of 3-dimensional conformal radiotherapy combined with chemotherapy for rectal cancer of postoperative local recurrence].
    Wu DH; Chen LH
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):901-3. PubMed ID: 15363248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
    de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Geisler D; Dietz DW; Lavery IC; Fazio VW; Kalady MF
    Ann Surg Oncol; 2011 Jun; 18(6):1590-8. PubMed ID: 21207164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraoperative radiotherapy of locally advanced and recurrent rectal cancer].
    Eble MJ; Kallinowski F; Wannenmacher MF; Herfarth C
    Chirurg; 1994 Jul; 65(7):585-92. PubMed ID: 7924596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of novel agents into combined-modality treatment for rectal cancer patients.
    Rödel C; Sauer R
    Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy for rectal cancer: current status and perspectives.
    Watanabe T; Kiyomatsu T; Kanazawa T; Tada T; Komuro Y; Tsurita G; Muto T; Nagawa H
    Int J Clin Oncol; 2004 Dec; 9(6):475-83. PubMed ID: 15616878
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radiotherapy in adenocarcinoma of the rectum. Results].
    Billebaud T; Molkhou JM; Houry S; Lacaine F; Huguier M
    Gastroenterol Clin Biol; 1985 May; 9(5):437-43. PubMed ID: 2408955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.